Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
PLoS Negl Trop Dis ; 15(11): e0009992, 2021 11.
Artigo em Inglês | MEDLINE | ID: mdl-34843475

RESUMO

Gambiense human African trypanosomiasis is a deadly disease that has been declining in incidence since the start of the Century, primarily due to increased screening, diagnosis and treatment of infected people. The main treatment regimen currently in use requires a lumbar puncture as part of the diagnostic process to determine disease stage and hospital admission for drug administration. Fexinidazole is a new oral treatment for stage 1 and non-severe stage 2 human African trypanosomiasis. The World Health Organization has recently incorporated fexinidazole into its treatment guidelines for human African trypanosomiasis. The treatment does not require hospital admission or a lumbar puncture for all patients, which is likely to ease access for patients; however, it does require concomitant food intake, which is likely to reduce adherence. Here, we use a mathematical model calibrated to case and screening data from Mushie territory, in the Democratic Republic of the Congo, to explore the potential negative impact of poor compliance to an oral treatment, and potential gains to be made from increases in the rate at which patients seek treatment. We find that reductions in compliance in treatment of stage 1 cases are projected to result in the largest increase in further transmission of the disease, with failing to cure stage 2 cases also posing a smaller concern. Reductions in compliance may be offset by increases in the rate at which cases are passively detected. Efforts should therefore be made to ensure good adherence for stage 1 patients to treatment with fexinidazole and to improve access to care.


Assuntos
Tripanossomicidas/administração & dosagem , Tripanossomíase Africana/tratamento farmacológico , Tripanossomíase Africana/transmissão , República Democrática do Congo/epidemiologia , Humanos , Modelos Teóricos , Trypanosoma brucei gambiense/efeitos dos fármacos , Trypanosoma brucei gambiense/fisiologia , Tripanossomíase Africana/epidemiologia , Tripanossomíase Africana/parasitologia
2.
J Infect Dis ; 221(Suppl 5): S499-S502, 2020 06 11.
Artigo em Inglês | MEDLINE | ID: mdl-32529261

RESUMO

As neglected tropical disease programs look to consolidate the successes of moving towards elimination, we need to understand the dynamics of transmission at low prevalence to inform surveillance strategies for detecting elimination and resurgence. In this special collection, modelling insights are used to highlight drivers of local elimination, evaluate strategies for detecting resurgence, and show the importance of rational spatial sampling schemes for several neglected tropical diseases (specifically schistosomiasis, soil-transmitted helminths, lymphatic filariasis, trachoma, onchocerciasis, visceral leishmaniasis, and gambiense sleeping sickness).


Assuntos
Erradicação de Doenças/estatística & dados numéricos , Doenças Negligenciadas/diagnóstico , Vigilância da População/métodos , Medicina Tropical , Humanos
3.
J Infect Dis ; 221(Suppl 5): S539-S545, 2020 06 11.
Artigo em Inglês | MEDLINE | ID: mdl-31876949

RESUMO

BACKGROUND: Gambiense human African trypanosomiasis ([gHAT] sleeping sickness) is a vector-borne disease that is typically fatal without treatment. Intensified, mainly medical-based, interventions in endemic areas have reduced the occurrence of gHAT to historically low levels. However, persistent regions, primarily in the Democratic Republic of Congo (DRC), remain a challenge to achieving the World Health Organization's goal of global elimination of transmission (EOT). METHODS: We used stochastic models of gHAT transmission fitted to DRC case data and explored patterns of regional reporting and extinction. The time to EOT at a health zone scale (~100 000 people) and how an absence of reported cases informs about EOT was quantified. RESULTS: Regional epidemiology and level of active screening (AS) both influenced the predicted time to EOT. Different AS cessation criteria had similar expected infection dynamics, and recrudescence of infection was unlikely. However, whether EOT has been achieved when AS ends is critically dependent on the stopping criteria. Two or three consecutive years of no detected cases provided greater confidence of EOT compared with a single year (~66%-75% and ~82%-84% probability of EOT, respectively, compared with 31%-51%). CONCLUSIONS: Multiple years of AS without case detections is a valuable measure to assess the likelihood that the EOT target has been met locally.


Assuntos
Trypanosoma brucei gambiense , Tripanossomíase Africana/diagnóstico , Tripanossomíase Africana/epidemiologia , República Democrática do Congo/epidemiologia , Erradicação de Doenças , Humanos , Modelos Biológicos , Processos Estocásticos , Tripanossomíase Africana/prevenção & controle
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA